Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2743882537;82538;82539 chr2:178563820;178563819;178563818chr2:179428547;179428546;179428545
N2AB2579777614;77615;77616 chr2:178563820;178563819;178563818chr2:179428547;179428546;179428545
N2A2487074833;74834;74835 chr2:178563820;178563819;178563818chr2:179428547;179428546;179428545
N2B1837355342;55343;55344 chr2:178563820;178563819;178563818chr2:179428547;179428546;179428545
Novex-11849855717;55718;55719 chr2:178563820;178563819;178563818chr2:179428547;179428546;179428545
Novex-21856555918;55919;55920 chr2:178563820;178563819;178563818chr2:179428547;179428546;179428545
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: N
  • RefSeq wild type transcript codon: AAT
  • RefSeq wild type template codon: TTA
  • Domain: Fn3-87
  • Domain position: 70
  • Structural Position: 102
  • Q(SASA): 0.3304
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
N/D rs2154161681 None 0.958 N 0.504 0.288 0.247322355667 gnomAD-4.0.0 1.59138E-06 None None None None N None 0 0 None 0 2.77546E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
N/A 0.7895 likely_pathogenic 0.8158 pathogenic -1.02 Destabilizing 0.968 D 0.595 neutral None None None None N
N/C 0.5704 likely_pathogenic 0.5795 pathogenic -0.065 Destabilizing 1.0 D 0.728 prob.delet. None None None None N
N/D 0.716 likely_pathogenic 0.7858 pathogenic -0.751 Destabilizing 0.958 D 0.504 neutral N 0.468886796 None None N
N/E 0.9055 likely_pathogenic 0.9253 pathogenic -0.642 Destabilizing 0.968 D 0.557 neutral None None None None N
N/F 0.9287 likely_pathogenic 0.9372 pathogenic -0.751 Destabilizing 0.995 D 0.74 deleterious None None None None N
N/G 0.7358 likely_pathogenic 0.7531 pathogenic -1.374 Destabilizing 0.968 D 0.421 neutral None None None None N
N/H 0.3492 ambiguous 0.3827 ambiguous -1.051 Destabilizing 0.142 N 0.281 neutral N 0.447234779 None None N
N/I 0.792 likely_pathogenic 0.7942 pathogenic -0.11 Destabilizing 0.994 D 0.739 prob.delet. N 0.468886796 None None N
N/K 0.8792 likely_pathogenic 0.9018 pathogenic -0.342 Destabilizing 0.958 D 0.576 neutral N 0.451677807 None None N
N/L 0.7377 likely_pathogenic 0.7538 pathogenic -0.11 Destabilizing 0.991 D 0.727 prob.delet. None None None None N
N/M 0.8024 likely_pathogenic 0.8067 pathogenic 0.412 Stabilizing 1.0 D 0.698 prob.neutral None None None None N
N/P 0.9786 likely_pathogenic 0.9778 pathogenic -0.383 Destabilizing 0.998 D 0.698 prob.neutral None None None None N
N/Q 0.8292 likely_pathogenic 0.8491 pathogenic -0.981 Destabilizing 0.991 D 0.678 prob.neutral None None None None N
N/R 0.8318 likely_pathogenic 0.8603 pathogenic -0.342 Destabilizing 0.991 D 0.676 prob.neutral None None None None N
N/S 0.2698 likely_benign 0.2873 benign -1.035 Destabilizing 0.958 D 0.438 neutral N 0.457448986 None None N
N/T 0.6471 likely_pathogenic 0.6711 pathogenic -0.728 Destabilizing 0.979 D 0.574 neutral N 0.419674458 None None N
N/V 0.7541 likely_pathogenic 0.7632 pathogenic -0.383 Destabilizing 0.995 D 0.717 prob.delet. None None None None N
N/W 0.9699 likely_pathogenic 0.9732 pathogenic -0.495 Destabilizing 1.0 D 0.731 prob.delet. None None None None N
N/Y 0.6132 likely_pathogenic 0.6294 pathogenic -0.297 Destabilizing 0.976 D 0.687 prob.neutral N 0.492106386 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.